Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-02-22

FDA Approved: FAMOTIDINE — Supplemental Application (Alembic Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for famotidine submitted by Alembic Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Famotidine (famotidine)

Snippet

SUPPL AP for FAMOTIDINE (FAMOTIDINE)